产品名称
蛋白酶抑制剂混合物套装III,无动物源性成分, Protease Inhibitor Cocktail Set III, Animal-Free, is a cocktail of six protease inhibitors with broad specificity for the inhibition of aspartic, cysteine & serine proteases & aminopeptidases.
form
liquid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, avoid repeated freeze/thaw cycles
solubility
water: soluble
shipped in
wet ice
storage temp.
−20°C
正在寻找类似产品? 访问 产品对比指南
General description
Biochem/physiol Actions
主要靶标
天冬氨酸、半胱氨酸和丝氨酸蛋白酶以及氨肽酶
天冬氨酸、半胱氨酸和丝氨酸蛋白酶以及氨肽酶
产物不与ATP竞争。
可逆:否
细胞可渗透性:否
Physical form
溶于1 ml DMSO。
Preparation Note
初次融化后,等分并冷冻(-20°C)。
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
毒性:刺激性(B)
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2
存储类别
10 - Combustible liquids
flash_point_f
188.6 °F
flash_point_c
87 °C
Li-Ping Gao et al.
ACS chemical neuroscience, 11(5), 814-829 (2020-02-13)
Mitophagy is an important process for removing damaged mitochondria in cells, the dysfunction of which has been directly linked to an increasing number of neurodegenerative disorders. However, the details of mitophagy in prion diseases still need to be deeply explored.
Jia Chen et al.
Virologica Sinica, 35(5), 614-625 (2020-04-22)
Activation of inflammatory cells and upregulations of a number of cytokines in the central nervous system (CNS) of patients with prion diseases are frequently observed. To evaluate the potential changes of some brain cytokines that were rarely addressed during prion
Sungsin Jo et al.
Arthritis research & therapy, 23(1), 301-301 (2021-12-10)
WNT16 is critical for bone homeostasis, but the effect of WNT16 in ankylosing spondylitis (AS) is still unknown. Here, we investigated whether WNT16 influences bone formation and pathophysiological changes of AS in an in vitro model. The bone tissue from
Ching-Hsin Huang et al.
Advanced therapeutics, 3(6) (2021-03-02)
Mono- or dual-checkpoint inhibitors for immunotherapy have changed the paradigm of cancer care; however, only a minority of patients responds to such treatment. Combining small molecule immuno-stimulators can improve treatment efficacy, but they are restricted by poor pharmacokinetics. In this
Dong-Min Kim et al.
Cell reports, 37(1), 109798-109798 (2021-09-30)
Despite the worldwide effect of the coronavirus disease 2019 (COVID-19) pandemic, the underlying mechanisms of fatal viral pneumonia remain elusive. Here, we show that critical COVID-19 is associated with enhanced eosinophil-mediated inflammation when compared to non-critical cases. In addition, we
相关内容
An Introduction to Inhibitors and Their Biological Applications
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持